NEW YORK ( TheStreet) -- These six stocks were upgraded by TheStreet Ratings to a buy on Tuesday: Southwest Airlines ( LUV), Macerich ( MAC), Hologic ( HOLX), Beam ( BEAM), Diebold ( DBD) and Associated Banc-Corp ( ASBC). Southwest Airlines The airline on Tuesday said revenue passenger miles in January fell 2.7% from the previous year to 7.4 billion. Southwest also announced last week that it was adding flights from Denver and Austin, Texas to Cancun. "Southwest Airlines expects 2012 capacity to be flat with 2011, which will help the company to improve passenger unit revenue to offset higher y/y jet fuel prices," Dahlman Rose analysts wrote in a Jan. 20 report. "With no capacity growth this year, Southwest expects mid- to high-single digit passenger unit revenue growth. January and February are expected to see growth of 7%-8%, with March expecting to slow." Southwest Airlines was upgraded to a buy from a hold by TheStreet Ratings. Of the 17 analysts who cover the stock, eight rated it a buy and an equal number considered it a hold. One analyst gave Southwest a sell rating. Southwest has an estimated price-to-earnings ratio for next year of 8.91. The average among the airlines is 8.46. Both Delta ( DAL) and United Continental Holdings ( UAL) have lower forward P/Es of 4.1 and 3.92, respectively. TheStreet Ratings gives Southwest a B- grade with a $11.60 price target. The stock closed Monday at $9.75; it has risen 13.9% year to date.
Hologic The surgical products company reported on Jan. 30 first-quarter earnings of $20.8 million, or 8 cents a share, an increase from year-ago fourth quarter earnings of $10.9 million, or 4 cents. "We are reiterating our OUTPERFORM rating and $24 price target following HOLX's Q1/12 earnings release," Barrington Research analysts wrote in a Feb. 1 report. "We believe the women's health market is an attractive market opportunity. Given that HOLX is the clear leader of this market, investors should be appropriately aligned with this positive trend given the current valuation of HOLX's shares." Hologic was upgraded to a buy from a hold by TheStreet Ratings. Of the 24 analysts who cover the company, 15 rated it a buy. Eight considerd Hologic a hold and one rated it a sell. Hologic has a forward P/E of 13.8. The average among medical supplies companies is 20.92. C.R. Bard ( BCR) and Alere ( ALR) both have lower forward P/Es of 13.29 and 9.55, respectively. TheStreet Ratings gives Hologic a B- grade and $24.37 price target. The stock closed Monday at $20.79 and has risen 18.73% year to date.
Diebold "Following strong 4Q results and 2012 guidance from NCR, we believe we have underestimated demand in the Financial Services vertical, and we are reintroducing growth into segment revenue in mid 2012," JPMorgan analysts wrote in a report Tuesday. "We still prefer NCR to DBD, but we believe DBD is positioned to perform in line with the mean of our coverage universe." The security and self-service delivery company was upgraded to neutral from underweight by JPMorgan on Tuesday. Diebold was upgraded to a buy from a hold by TheStreet Ratings. Of the 10 analysts who cover the company, seven rated it a hold. Two analysts considered it a buy and one gave Diebold a sell rating. Diebold has a forward P/E of 14.41. The average among computer hardware companies is 21.81. Lexmark ( LXK) and Ingram Micro ( IM) have lower forward P/Es of 8.17 and 9.9, respectively. TheStreet Ratings gives Diebold a B grade and $38.37 price target. The stock closed Monday at $33.24 and has increased 10.54% year to date.